Latin America Rare Biomarkers Specimen Collection And Stabilization Market Size & Outlook
Latin America rare biomarkers specimen collection and stabilization market, 2018-2030 (US$M)
Related Markets
Latin America rare biomarkers specimen collection and stabilization market highlights
- The Latin America rare biomarkers specimen collection and stabilization market generated a revenue of USD 935.9 million in 2023.
- The market is expected to grow at a CAGR of 12.2% from 2024 to 2030.
- In terms of segment, circulating cell free dna (ccfdna) was the largest revenue generating biomarker in 2023.
- Circulating Cell Free DNA (ccfDNA) is the most lucrative biomarker segment registering the fastest growth during the forecast period.
Latin America data book summary
| Market revenue in 2023 | USD 935.9 million |
| Market revenue in 2030 | USD 2,093.9 million |
| Growth rate | 12.2% (CAGR from 2023 to 2030) |
| Largest segment | Circulating cell free dna (ccfdna) |
| Fastest growing segment | Circulating Cell Free DNA (ccfDNA) |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Circulating Cell Free DNA (ccfDNA) |
| Key market players worldwide | Qiagen NV, Charles River Laboratories International Inc, Roche Holding AG ADR, Thermo Fisher Scientific Inc, Eurofins Scientific SE, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Merck KGaA, Siemens Healthineers AG ADR |
Other key industry trends
- In terms of revenue, Latin America region accounted for 2.5% of the global rare biomarkers specimen collection and stabilization market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 12,677.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Biomarkers Specimen Collection And Stabilization Market Scope
Rare Biomarkers Specimen Collection And Stabilization Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America rare biomarkers specimen collection and stabilization market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare biomarkers specimen collection and stabilization market will help companies and investors design strategic landscapes.
Circulating cell free dna (ccfdna) was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Latin America rare biomarkers specimen collection and stabilization market based on circulating cell free dna (ccfdna) covering the revenue growth of each sub-segment from 2018 to 2030.
Presence of companies like Novagen that offer BabyGen NIPT in Argentina has accelerated reproductive and prenatal genetic space in the region. A considerable number of research studies are being performed in the region to evaluate the role of biomarkers in cancer management. These factors have aided in the organic revenue growth for companies that are involved in marketing of biomarker isolation kits.
Reasons to subscribe to Latin America rare biomarkers specimen collection and stabilization market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America rare biomarkers specimen collection and stabilization market databook
-
Our clientele includes a mix of rare biomarkers specimen collection and stabilization market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America rare biomarkers specimen collection and stabilization market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America rare biomarkers specimen collection and stabilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America rare biomarkers specimen collection and stabilization market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
